Market Research Logo

Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global 3D Cell Culture Market Research Report 2016 by OBRC, is an extensive study on present state of the 3D Cell Culture Market.

3D cell culture allows culturing of cells in a 3D environment. Adoption rate of 3D cell culture is high amongst research labs, hospitals, and pharmaceutical, biopharmaceutical & biotechnology companies for the forecasted period. Cell biologics, diseases associated to liver, cancer cell therapy are set to drive 3D cell culture market. New innovations in tissue engineering and 3D printing technology have supplemented organ harvesting and transplant. Cell based therapies in hospitals and diagnostic centres for oncology patient are set to propel 3D cell culture market for the forecasted period. Increasing rate of consumers in healthcare in North America and Europe, emerging markets like India and China, are projected to fuel the growth of 3D cell culture market.

Increasing cell based research and new innovations in cell culture are the factors driving 3D cell culture market for the forecasted period. Growing demand for organ transplantation and increasing research & development investments are the opportunities in 3D cell culture market for the forecasted period.

High investments for cell biology research and shortage of infrastructure for cell based research in emerging countries can impact 3D cell culture market for the forecasted period. Variation in 3D cell culture products is a major challenge for the 3D cell culture market.

The research report is segmented in terms of technology, applications, and end users. Technology segmented, is further sub segmented into with scaffold and without scaffold. Without scaffold technology segment is divided further into 3D bioreactors, 3D petri-dishes, 3D bio-printing, microfluidics and hanging drop plates. With scaffold technology segments is classified into solid structure scaffold, hydrogels/ECM and micro-patterned surfaces. Application segment is sub segmented into tissue engineering, cell based assay, oncology, in vivo applications of stem cells, 3D printing, and other applications. End user segment is classified into biotechnology and pharmaceutical industries, research laboratories, hospitals and diagnostic centres, and other end users. Biotechnology and pharmaceutical industries are the leading end user segment for 3D cell culture market for the forecasted period.

Some of the leading companies in 3D cell culture market are, Thermo Fisher Scientific Ltd., Corning Incoporated., Lonza A. G., Sigma-Aldrich Co. LLC., Hi Media Laboratories., Promocell GmBH., 3D Biotek LLC., Bell Brook Labs., Kurray Co. Ltd., and Global Cell Solutions. The report provides comprehensive information like company profile, sales, revenue, market share and contact information.

Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in 3D cell culture market, to increase their global presence. Research & development investments are high with the urge to develop quality products. Pluristem Therapeutics on 15th April 2016 was granted patent by Japan Patent Office on 3D cell culture method for cell based therapies from placental cells against hematopoietic diseases caused by chemotherapy or failed transplants.

Small biotechnology firms with unique and differentiated assets are driving innovation in 3D cell culture market. Singapore based Genome Institute of Singapore and Alabama based Vivo Bioscience Inc., has partnered for a joint research towards precision oncology on 30th September 2016.

The research report analysed 3D cell culture market geographically. Region wise the report is segmented as North America, Europe, Asia Pacific, and Rest of the World.

North America is the largest 3D cell culture market followed by Europe. North American markets are driven by demand for organ transplants, increasing investment inn oncology research and favourable regulatory environment. Increasing research towards cell biology, biotechnology and oncology both at university and industrial levels are driving the growth of 3D Cell Culture market in Europe, for the forecasted period. UK is a major in Europe for 3D cell culture with increasing investments for cancer research.

Asia Pacific is the fastest growing market for 3D cell culture market. Increasing government investment in the area of cell biology and oncology research, growing talent pool towards cell biology research, and new regulatory reforms are the driving force behind 3D Cell culture market in Asia Pacific. China and India are the leading markets in Asia Pacific, with growing awareness of organ transplantation and increasing investment cancer research being the driving factors.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
2. MARKET OVERVIEW
2.1. GLOBAL 3D CELL CULTURE MARKET: EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. MANUFACTURING PROCESS
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.7. ROI ANALYSIS
2.7.8. GAP ANALYSIS
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS & MARKET IMPACT
3.1.1. INCREASING CELL BASED RESEARCH
3.1.2. NEW INNOVATIONS IN CELL CULTURE
3.1.3. TECHNOLOGICAL ADVANCEMENTS IN CELL BIOLOGY RESEARCH
3.1.4. RISING FUNDING FOR RESEARCH RELATED ACTIVITIES
3.1.5. ADOPTION OF 3D CELL CULTURE TECHNOLOGY
3.2. MARKET RESTRAINTS & MARKET IMPACT
3.2.1. HIGH INVESTMENTS FOR CELL BIOLOGY RESEARCH
3.2.2. SHORTAGE OF INFRASTRUCTURE FOR CELL BASED RESEARCH IN EMERGING COUNTRIES
3.2.3. STRINGENT REGULATORY RULES DELAYING PRODUCT APPROVAL
3.3. MARKET OPPORTUNITIES
3.3.1. GROWING DEMAND FOR ORGAN TRANSPLANT
3.3.2. INCREASING R&D INVESTMENTS
3.3.3. GROWING HEALTHCARE MARKET
3.4. MARKET CHALLENGES
3.4.1. VARIATION IN 3D CELL CULTURE PRODUCTS
3.4.2. VARYING REGULATORY COMPLIANCE RULES.
4. MARKET SEGMENTATION
4.1. GLOBAL 3D CELL CULTURE MARKET BY TECHNOLOGY 2014-2022
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. WITHOUT SCAFFOLD 2014-2022 ($ MILLION)
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.1.6. WITHOUT SCAFFOLD BY SUB SEGMENTS
4.1.5.1.6.1. 3D BIOREACTORS
4.1.5.1.6.2. 3D PETRI-DISHES
4.1.5.1.6.3. 3D BIO-PRINTING
4.1.5.1.6.4. MICROFLUIDICS
4.1.5.1.6.5. HANGING DROP PLATES
4.1.5.2. WITH SCAFFOLD 2014-2022
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.2.6. WITH SCAFFOLD BY SUB SEGMENTS
4.1.5.2.6.1. MICRO-PATTERNED SURFACES
4.1.5.2.6.2. HYDROGELS/ECM
4.1.5.2.6.3. SOLID STRUCTURE SCAFFOLD
4.2. GLOBAL 3D CELL CULTURE MARKET BY APPLICATIONS 2014-2022 ($ MILLION)
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. TISSUE ENGINEERING 2014-2022 ($ MILLION)
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. CELL BASED ASSAY 2014-2022 ($ MILLION)
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. ONCOLOGY 2014-2022 ($ MILLION)
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. IN VIVO APPLICATIONS OF STEM CELLS 2014-2022 ($ MILLION)
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. 3D PRINTING 2014-2022 ($ MILLION)
4.2.5.5.1. APPLICATIONS
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.2.5.6. OTHER APPLICATIONS 2014-2022 ($ MILLION)
4.2.5.6.1. APPLICATIONS
4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.5. KEY CONCLUSIONS
4.3. GLOBAL 3D CELL CULTURE MARKET BY END USERS 2014-2022 ($ MILLION)
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. BIOTECHNOLOGY, BIOPHARMACEUTICAL & PHARMACEUTICAL INDUSTRIES
4.3.5.1.1. APPLICATIONS
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. RESEARCH LABORATORIES
4.3.5.2.1. APPLICATIONS
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. HOSPITALS & DIAGNOSTICS CENTERS
4.3.5.3.1. APPLICATIONS
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. OTHER END USERS
4.3.5.4.1. APPLICATIONS
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS – DASHBOARD
6. GLOBAL 3D CELL CULTURE MARKET BY REGION (REVENUE ANALYSIS) 2014-2022 ($ MILLION)
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.1.2.1.3. PRICE ANALYSIS
6.4.1.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.5. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.1.2.2.3. PRICE ANALYSIS
6.4.1.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.5. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.1.3. PRICE ANALYSIS
6.4.2.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.5. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.2.3. PRICE ANALYSIS
6.4.2.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.5. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.3.3. PRICE ANALYSIS
6.4.2.2.3.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.5. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.4.3. PRICE ANALYSIS
6.4.2.2.4.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.5. KEY CONCLUSIONS
6.4.2.2.5. ITALY
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.5.3. PRICE ANALYSIS
6.4.2.2.5.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.5. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.6.3. PRICE ANALYSIS
6.4.2.2.6.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.5. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.1.3. PRICE ANALYSIS
6.4.3.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.5. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.2.3. PRICE ANALYSIS
6.4.3.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.5. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.3.3. PRICE ANALYSIS
6.4.3.2.3.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.5. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.4.3. PRICE ANALYSIS
6.4.3.2.4.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.5. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.5.3. PRICE ANALYSIS
6.4.3.2.5.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.5. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.6.3. PRICE ANALYSIS
6.4.3.2.6.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.5. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.1.3. PRICE ANALYSIS
6.4.4.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.5. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & NORTH AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.2.3. PRICE ANALYSIS
6.4.4.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.5. KEY CONCLUSIONS
6.4.4.2.3. AFRICA
6.4.4.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.3.3. PRICE ANALYSIS
6.4.4.2.3.4. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.3.5. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ARMACELL GMBH
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.2. BASF SE
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.3. FLETCHER INSULATION
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.4. JOHNS MANVILLE INC.
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.5. KINGSPAN GROUP PLC
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. KNAUF INSULATION GMBH
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.7. OWENS CORNING
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.8. PAROC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.9. ROCKWOOL INTERNATIONAL A/S
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.10. SAINT-GOBAIN SA
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.11. LONZA LTD
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.12. SYNTHECON INC.,
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. PLURISTEM THERAPEUTICS LTD.,
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.14. ORGANOGENIX INC.,
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.15. VIVO BIOSCIENCE INC.,
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL CELL CULTURE MARKET BY TECHNOLOGY ($ MILLION)
GLOBAL WITHOUT SCAFFOLD BY GEOGRAPHY ($ MILLION)
GLOBAL BIOREACTORS BY GEOGRAPHY ($ MILLION)
GLOBAL PETRI-DISHES BY GEOGRAPHY ($ MILLION)
GLOBAL BIO-PRINTING BY GEOGRAPHY ($ MILLION)
GLOBAL MICROFLUIDICS BY GEOGRAPHY ($ MILLION)
GLOBAL HANGING DROP PLATES BY GEOGRAPHY ($ MILLION)
GLOBAL WITH SCAFFOLD MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL MICRO-PATTERNED BY GEOGRAPHY ($ MILLION)
GLOBAL HYDROGELS/ECM BY GEOGRAPHY ($ MILLION)
GLOBAL SOLID STRUCTURE SCAFFOLD BY GEOGRAPHY ($ MILLION)
GLOBAL CELL CULTURE MARKET BY APPLICATIONS ($ MILLION)
GLOBAL TISSUE ENGINEERING BY GEOGRAPHY ($ MILLION)
GLOBAL CELL BASED ASSAY BY GEOGRAPHY ($ MILLION)
GLOBAL ONCOLOGY BY GEOGRAPHY ($ MILLION)
GLOBAL IN VIVO APPLICATIONS OF STEM CELLS BY GEOGRAPHY ($ MILLION)
GLOBAL PRINTING BY GEOGRAPHY ($ MILLION)
GLOBAL OTHER APPLICATIONS BY GEOGRAPHY ($ MILLION)
GLOBAL CELL CULTURE MARKET BY END USERS ($ MILLION)
GLOBAL LIFE SCIENCE INDUSTRY BY GEOGRAPHY ($ MILLION)
GLOBAL RESEARCH LABORATORIES BY GEOGRAPHY ($ MILLION)
GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS BY GEOGRAPHY ($ MILLION)
GLOBAL OTHER END USERS BY GEOGRAPHY ($ MILLION)
NORTH AMERICA CELL CULTURE MARKET ($ MILLION)
EUROPE CELL CULTURE MARKET ($ MILLION)
ASIA PACIFIC CELL CULTURE MARKET ($ MILLION)
REST OF THE WORLD CELL CULTURE MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL CELL CULTURE MARKET BY WITHOUT SCAFFOLD ($ MILLION)
GLOBAL CELL CULTURE MARKET BY BIOREACTOR ($ MILLION)
GLOBAL CELL CULTURE MARKET BY PETRI DISHES ($ MILLION)
GLOBAL CELL CULTURE MARKET BY BIO-PRINTING ($ MILLION)
GLOBAL CELL CULTURE MARKET BY HANGING DROP PLATES ($ MILLION)
GLOBAL CELL CULTURE MARKET BY MICROFLUIDICS ($ MILLION)
GLOBAL CELL CULTURE MARKET BY WITH SCAFFOLD ($ MILLION)
GLOBAL CELL CULTURE MARKET BY MICRO-PATTERNED ($ MILLION)
GLOBAL CELL CULTURE MARKET BY HYDROGELS/ECM ($ MILLION)
GLOBAL CELL CULTURE MARKET BY SOLID STRUCTURE ($ MILLION)
GLOBAL CELL CULTURE MARKET BY TISSUE ENGINEERING ($ MILLION)
GLOBAL CELL CULTURE MARKET BY CELL BASED ASSAY ($ MILLION)
GLOBAL CELL CULTURE MARKET BY IN VIVO APPLICATIONS ($ MILLION)
GLOBAL CELL CULTURE MARKET BY OTHER APPLICATIONS ($ MILLION)
GLOBAL CELL CULTURE MARKET BY LIFE SCIENCE INDUSTRY ($ MILLION)
GLOBAL CELL CULTURE MARKET BY RESEARCH LABORATORIES ($ MILLION)
GLOBAL CELL CULTURE MARKET BY HOSPITAL AND DIAGNOSTICS CENTERS ($ MILLION)
GLOBAL CELL CULTURE MARKET BY OTHER END USERS ($ MILLION)
UNITED STATES (U.S.) CELL CULTURE MARKET ($ MILLION)
CANADA CELL CULTURE MARKET ($ MILLION)
UNITED KINGDOM (UK) CELL CULTURE MARKET ($ MILLION)
FRANCE CELL CULTURE MARKET ($ MILLION)
GERMANY CELL CULTURE MARKET ($ MILLION)
SPAIN CELL CULTURE MARKET ($ MILLION)
ITALY CELL CULTURE MARKET ($ MILLION)
ROE CELL CULTURE MARKET ($ MILLION)
INDIA CELL CULTURE MARKET ($ MILLION)
CHINA CELL CULTURE MARKET ($ MILLION)
JAPAN CELL CULTURE MARKET ($ MILLION)
KOREA CELL CULTURE MARKET ($ MILLION)
AUSTRALIA CELL CULTURE MARKET ($ MILLION)
ROAPAC CELL CULTURE MARKET ($ MILLION)
LATIN AMERICA CELL CULTURE MARKET ($ MILLION)
MENA CELL CULTURE MARKET ($ MILLION)
AFRICA 3D CELL CULTURE MARKET 2014-2022 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report